phase 2_completion
saveZhejiang University Hospital One — serplulimab (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer